Form4insider filings, from the source

SEC Form 4 · accession 0000904454-17-000055

MARINUS PHARMACEUTICALS INC · MRNS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Nicole Vitullo
Director · 10% Owner
Period of report
Jan 17, 2017
Accepted (ET)
Jan 19, 2017 · 4:42 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001267813

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1Jan 17, 2017A4,500$0.00A7,800D
Common StockF3holding———2,476,886IBy Domain Partners VI, L.P.
Common StockF3holding———17,000IBy DP VI Associates, L.P.
Common StockF3holding———42,550IBy Domain Associates, LLC

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy)F2$1.21Jan 17, 2017A10,500A—Jan 17, 2027Common Stock10,50010,500D

Explanation of responses